Cost of hepatocellular carcinoma to the national health service in England: a registry-based analysis
Katherine Cullen, Deborah Fitzsimmons(Swansea University), Graeme Alexander(University of Cambridge), Rhys Pockett(Cancer Research UK Scotland Institute), Lizz Paley, Daniela Tataru(National Health Service), Mari Jones(Swansea University), Timothy Cross(University of Liverpool), Anya Burton(Public Health England), Aileen Marshall(The Royal Free Hospital), Ian Rowe(University of Leeds)
Cited by 9
Related Papers
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
|Science|2004|1.2k
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
|Journal of Hepatology|2020|525
Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation
|JHEP Reports|2021|69
(untitled)
|Discovery Research Portal (University of Dundee)|2022|62